BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17943851)

  • 1. Copper containing, framed intra-uterine devices for contraception.
    Kulier R; O'Brien PA; Helmerhorst FM; Usher-Patel M; D'Arcangues C
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005347. PubMed ID: 17943851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper-containing, framed intrauterine devices for contraception: a systematic review of randomized controlled trials.
    O'Brien PA; Kulier R; Helmerhorst FM; Usher-Patel M; d'Arcangues C
    Contraception; 2008 May; 77(5):318-27. PubMed ID: 18402846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper containing, framed intra-uterine devices for contraception.
    Kulier R; Helmerhorst FM; O'Brien P; Usher-Patel M; d'Arcangues C
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005347. PubMed ID: 16856094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestin intrauterine devices versus copper intrauterine devices for emergency contraception.
    Ramanadhan S; Goldstuck N; Henderson JT; Che Y; Cleland K; Dodge LE; Edelman A
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013744. PubMed ID: 36847591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
    French R; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Guillebaud J
    Cochrane Database Syst Rev; 2001; (2):CD001776. PubMed ID: 11406007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate postabortal insertion of intrauterine devices.
    Grimes D; Schulz K; Stanwood N
    Cochrane Database Syst Rev; 2002; (3):CD001777. PubMed ID: 12137634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the performances of TCu380A and TCu380S IUDs up to five years.
    Bahamondes L; Díaz J; Petta C; Monteiro I; Monteiro CD; Regina CH
    Adv Contracept; 1999; 15(4):275-81. PubMed ID: 11145369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the frameless GyneFix and the TCu380A IUDs in a 3-year multicenter, randomized, comparative trial in parous women.
    Wu S; Hu J; Wildemeersch D
    Contraception; 2000 Feb; 61(2):91-8. PubMed ID: 10802273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frameless versus classical intrauterine device for contraception.
    O'Brien PA; Marfleet C
    Cochrane Database Syst Rev; 2001; (4):CD003282. PubMed ID: 11687184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postpartum IUDS: keys for success.
    O'Hanley K; Huber DH
    Contraception; 1992 Apr; 45(4):351-61. PubMed ID: 1516367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper containing intra-uterine devices versus depot progestogens for contraception.
    Hofmeyr GJ; Singata M; Lawrie TA
    Cochrane Database Syst Rev; 2010 Jun; 2010(6):CD007043. PubMed ID: 20556773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrauterine devices.
    Mccarthy TG; Ratnam SS
    Contemp Rev Obstet Gynaecol; 1992 Oct; 4(4):215-22. PubMed ID: 12345158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statement on intrauterine devices (IUDs).
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1987 Dec; 21(6):3-5. PubMed ID: 12268853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
    Chi IC
    Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frameless copper IUD (GyneFix) and the TCu380A IUD: results of an 8-year multicenter randomized comparative trial.
    Meirik O; Rowe PJ; Peregoudov A; Piaggio G; Petzold M;
    Contraception; 2009 Aug; 80(2):133-41. PubMed ID: 19631788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of three copper IUDs (MLCu250, MLCu375 and Nova-T).
    Bratt H; Skjeldestad FE; Cullberg Valentin K
    Acta Obstet Gynecol Scand; 1988; 67(3):247-51. PubMed ID: 3051876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
    Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
    Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.